Quantcast Acelity - KCI Expands Surgical Portfolio with Launch of PREVENA RESTOR BELLA•FORM™ Incision Management System at Plastic Surgery the Meeting
MENU

KCI Expands Surgical Portfolio with Launch of PREVENA RESTOR BELLA•FORM™ Incision Management System at Plastic Surgery the Meeting

New Precision-Designed System Protects and Optimizes Post-Operative Care by Delivering Negative Pressure to the Incision and Surrounding Soft Tissue

September 20, 2019 | SAN ANTONIO
KCI, an Acelity Company, today announced the availability of PREVENA RESTOR BELLA•FORM™ System, specifically designed to manage post-operative incisions, as well as the surrounding soft tissue envelope following surgical procedures, to stabilize the incision and surrounding surgical area, reduce edema and help improve healing. This launch is the first of the PREVENA RESTOR™ Therapy offering, a new portfolio that further optimizes post-surgical care and expands the Company’s surgical offerings.

“With the introduction of the PREVENA RESTOR BELLA•FORM™ System, we are advancing how surgeons can care for patients recovering from surgery, such as reconstructive soft tissue procedures. This first-to-market therapy was built specifically with the patient’s recovery journey in mind,” said R. Andrew Eckert, Chief Executive Officer, KCI. “The PREVENA RESTOR BELLA•FORM™ System addresses a significant clinical need by reimagining the traditional applications of negative pressure and thinking beyond the incision to help support improved healing in aspirational ways—all backed by the undisputed outcomes of PREVENA™ Therapy.”
 
“Particularly, when it comes to reconstructive procedures, clinicians and patients are dealing with a variety of challenges that are unavoidable because of the nature of the procedure, including compromised blood flow and tissue loss,” said Ronald Silverman, MD, FACS, Chief Medical Officer, KCI. “With the PREVENA RESTOR BELLA•FORM™ System, clinicians are able to not only protect the incisions against external contaminants, but they are also able to stabilize the incision and surrounding surgical area, with the goal of lowering the risk of surgical site complications. This may lead to better outcomes and help health care providers discharge their patients with confidence.”

The PREVENA RESTOR BELLA•FORM™ System encompasses the same proven technology as the PREVENA™ Incision Management System, with added benefits including:
• Extended therapy time: up to 14 days (dressing change required after 7 days);
• Expanded coverage area: dressing seamlessly conforms to patient;
• Precision design: larger dressing delivers therapy to incision and surrounding soft tissue envelope;
• Stabilize the reconstruction: mechanically stabilize the incision and surrounding soft tissue;
• Easy to apply: peel and place the form-fitting dressing

“As a plastic surgeon that specializes in breast reconstruction, I know that these types of surgeries can be incredibly complex. Not only do you run the risk of surgical site complications, but you also see patients whose breast compartment can collapse, further complicating an already emotional surgery,” said Allen Gabriel, MD, FACS. “I want my patients to have positive clinical outcomes, and also to be happy with their results, helping restore their sense of self after a life-altering diagnosis and surgery. With the introduction of the PREVENA RESTOR BELLA•FORM™ System, I can take my post-operative care one step further by offering patients a therapy that protects the incision and helps manage the environment, putting my patients at ease during their recovery.”

In a 2018 report, the American Society of Plastic Surgeons (ASPS) stated that there were more than 5.8 million reconstructive plastic surgery procedures in the United States. 
 
The PREVENA RESTOR BELLA•FORM™ System will be on display at booth #1435 during Plastic Surgery The Meeting, September 20-23, 2019, at the San Diego Convention Center.

About PREVENA RESTOR BELLA•FORM™ Incision Management System
The PREVENA RESTOR™ Incision Management System is intended to manage the environment of surgical incisions that continue to drain following sutured or stapled closure by maintaining a closed environment and removing exudates via the application of negative pressure wound therapy.
Please refer to the PREVENA RESTOR BELLA•FORM™ System instructions for use for important safety information.

About KCI, an Acelity Company
KCI, an Acelity Company, is a well trusted brand in advanced wound care. We are a leader in negative pressure wound therapy, providing solutions for both wound healing and surgical management. Our product offerings are available in more than 90 countries and deliver value through solutions that speed healing. KCI is a leader in quality, safety and customer experience and is committed to advancing the science of healing. Headquartered in San Antonio, Texas, KCI employs approximately 4,500 people worldwide.
 
References:
1. American Society of Plastic Surgeons, “2018 National Plastic Surgery Statistics.” Retrieved from https://www.plasticsurgery.org/documents/News/Statistics/2018/plastic-surgery-statistics-report-2018.pdf
 

For more information, contact:

Maggie Fairchild
Corporate Communications
Phone: +1-210-330-2666
Email: maggie.fairchild@acelity.com
 
Caleb Moore
Investor Relations
Phone: +1 210-255-6433
Email: caleb.moore@acelity.com
 

Footer Navigation